These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21725630)

  • 1. Double-phase (131)I whole body scan and (131)I SPECT-CT images in patients with differentiated thyroid cancer: their effectiveness for accurate identification.
    Wakabayashi H; Nakajima K; Fukuoka M; Inaki A; Nakamura A; Kayano D; Kinuya S
    Ann Nucl Med; 2011 Nov; 25(9):609-15. PubMed ID: 21725630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131)I scintigraphy for thyroid cancer.
    Aide N; Heutte N; Rame JP; Rousseau E; Loiseau C; Henry-Amar M; Bardet S
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2075-84. PubMed ID: 19276233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. I-131 SPECT/CT elucidates cryptic findings on planar whole-body scans and can reduce needless therapy with I-131 in post-thyroidectomy thyroid cancer patients.
    Blum M; Tiu S; Chu M; Goel S; Friedman K
    Thyroid; 2011 Nov; 21(11):1235-47. PubMed ID: 22007920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
    Chen L; Luo Q; Shen Y; Yu Y; Yuan Z; Lu H; Zhu R
    J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of 131I SPECT/CT on the management of differentiated thyroid carcinoma outpatients with radioablation].
    Mizokami D; Kosuda S; Shiotani A; Kinoshita F; Saotome K; Morozumi K
    Nihon Jibiinkoka Gakkai Kaiho; 2014 May; 117(5):673-80. PubMed ID: 24956745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancer.
    Oh JR; Byun BH; Hong SP; Chong A; Kim J; Yoo SW; Kang SR; Kim DY; Song HC; Bom HS; Min JJ
    Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1459-68. PubMed ID: 21505897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of (99m)Tc-pertechnetate whole body scan with neck and chest SPECT/CT for detection of post-surgical thyroid remnant and metastasis in differentiated thyroid cancer patients.
    Chantadisai M; Kingpetch K
    Ann Nucl Med; 2014 Aug; 28(7):674-82. PubMed ID: 24889127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a
    Spanu A; Nuvoli S; Marongiu A; Gelo I; Mele L; Piras B; Madeddu G
    BMC Cancer; 2020 Mar; 20(1):239. PubMed ID: 32197595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.
    Maruoka Y; Abe K; Baba S; Isoda T; Sawamoto H; Tanabe Y; Sasaki M; Honda H
    Radiology; 2012 Dec; 265(3):902-9. PubMed ID: 23012466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels.
    Leboulleux S; El Bez I; Borget I; Elleuch M; Déandreis D; Al Ghuzlan A; Chougnet C; Bidault F; Mirghani H; Lumbroso J; Hartl D; Baudin E; Schlumberger M
    Thyroid; 2012 Aug; 22(8):832-8. PubMed ID: 22853728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 131I SPECT/CT in the follow-up of patients with differentiated thyroid carcinoma.
    Menges M; Uder M; Kuwert T; Schmidt D
    Clin Nucl Med; 2012 Jun; 37(6):555-60. PubMed ID: 22614186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
    Ozkan E; Aras G; Kucuk NO
    Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
    Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
    Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis.
    Dong MJ; Liu ZF; Zhao K; Ruan LX; Wang GL; Yang SY; Sun F; Luo XG
    Nucl Med Commun; 2009 Aug; 30(8):639-50. PubMed ID: 19512954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.
    Na SJ; Yoo IeR; O JH; Lin C; Lin Q; Kim SH; Chung SK
    Ann Nucl Med; 2012 Jan; 26(1):26-34. PubMed ID: 21971605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Adding SPECT/CT Imaging to Post-Therapeutic Radioiodine Whole-Body Scan in Patients with Differentiated Thyroid Cancer.
    Sriprapaporn J; Sethanandha C; Yingsa-nga T; Komoltri C; Thongpraparn T; Harnnanthawiwai C
    J Med Assoc Thai; 2015 Jun; 98(6):596-605. PubMed ID: 26219165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Differentiated Thyroid Cancer and Recurrent Laryngeal Nerve Function with 131 Iodine Based on Positron Emission Tomography/Computed Tomography Image Segmentation Algorithm.
    Zhong Y; He J; Zhang C; Ardlee B
    World Neurosurg; 2021 May; 149():428-435. PubMed ID: 33166689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of [(18)F]-fluorodeoxy-D-glucose positron emission tomography and computed tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients following initial radioactive iodine ablation therapy.
    Kim MH; O JH; Ko SH; Bae JS; Lim DJ; Kim SH; Baek KH; Lee JM; Kang MI; Cha BY; Lee KW
    Thyroid; 2012 Feb; 22(2):157-64. PubMed ID: 22224820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m-pertechnetate whole-body SPET/CT scan in thyroidectomized differentiated thyroid cancer patients is a useful imaging modality in detecting remnant thyroid tissue, nodal and distant metastases before
    Lou K; Gu Y; Hu Y; Wang S; Shi H
    Hell J Nucl Med; 2018; 21(2):121-124. PubMed ID: 30089313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data.
    Vural GU; Akkas BE; Ercakmak N; Basu S; Alavi A
    Clin Nucl Med; 2012 Oct; 37(10):953-9. PubMed ID: 22899202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.